| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.08B | 96.00B | 91.92B | 90.45B | 87.03B | 85.10B |
| Gross Profit | 31.38B | 32.51B | 30.16B | 27.55B | 28.96B | 29.52B |
| EBITDA | 7.47B | 8.42B | 6.24B | 4.50B | 6.25B | 7.58B |
| Net Income | 4.91B | 4.46B | 2.50B | -885.00M | 1.35B | 2.67B |
Balance Sheet | ||||||
| Total Assets | 127.11B | 134.52B | 128.54B | 123.22B | 122.31B | 123.79B |
| Cash, Cash Equivalents and Short-Term Investments | 30.29B | 35.18B | 27.08B | 25.55B | 24.46B | 28.30B |
| Total Debt | 15.09B | 13.83B | 15.25B | 14.12B | 12.19B | 12.52B |
| Total Liabilities | 46.76B | 50.25B | 50.31B | 47.07B | 49.86B | 53.29B |
| Stockholders Equity | 78.69B | 82.60B | 76.56B | 73.03B | 69.27B | 66.98B |
Cash Flow | ||||||
| Free Cash Flow | -1.39B | 5.25B | 732.00M | 2.19B | -1.03B | 963.00M |
| Operating Cash Flow | 367.50M | 7.78B | 5.30B | 5.66B | 2.95B | 4.69B |
| Investing Cash Flow | -2.29B | -2.38B | -3.81B | -5.66B | -5.02B | -4.27B |
| Financing Cash Flow | 404.50M | -2.01B | 275.00M | 1.15B | -1.64B | 539.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥95.00B | 12.01 | ― | 1.71% | 5.83% | 28.79% | |
72 Outperform | ¥311.68B | 10.39 | 7.48% | 1.79% | 4.76% | 15.92% | |
70 Outperform | ¥31.22B | 7.06 | ― | 1.67% | 4.43% | 77.99% | |
70 Outperform | ¥942.11B | 17.91 | 5.45% | 1.30% | 4.46% | 21.24% | |
69 Neutral | ¥681.32B | 11.71 | 6.38% | 1.03% | 4.87% | 24.30% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
46 Neutral | ¥579.95B | 118.03 | -2.45% | 1.40% | 0.20% | 91.85% |